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Summary
Oxidative stress and telomere attrition are considered the driving
factors of aging. As oxidative damage to telomeric DNA favors
the erosion of chromosome ends and, in turn, telomere shorten-
ing increases the sensitivity to pro-oxidants, these two factors
may trigger a detrimental vicious cycle. To check whether limiting
oxidative stress slows down telomere shortening and related
progeria, we have investigated the effect of p66SHC deletion,
which has been shown to reduce oxidative stress and mitochon-
drial apoptosis, on late-generation TERC (telomerase RNA com-
ponent)-deficient mice having short telomeres and reduced
lifespan. Double mutant (TERC/ p66SHC/) mice were gener-
ated, and their telomere length, fertility, and lifespan investi-
gated in different generations. Results revealed that p66SHC
deletion partially rescues sterility and weight loss, as well as
organ atrophy, of TERC-deficient mice, but not their short
lifespan and telomere erosion. Therefore, our data suggest that
p66SHC-mediated oxidative stress and telomere shortening syn-
ergize in some tissues (including testes) to accelerate aging;
however, early mortality of late-generation mice seems to be
independent of any link between p66SHC-mediated oxidative
stress and telomere attrition.
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Introduction
Telomeres are conserved repetitive DNA sequences at the ends of
chromatids that protect from chromosomal rearrangements and loss of
genetic information (Blackburn et al., 2006). Shortening of telomeres
occurs in somatic cells during aging (Daniali et al., 2013) due to DNA
damage and incomplete end processing (von Zglinicki et al., 2000).
Above a threshold, telomere erosion results in the arrest of cellular
proliferation and the dysfunction of renewable tissues. For this reason,
telomerase activity and recombination-based processes that maintain
telomere length are critical for tissue homeostasis (Sahin & Depinho,
2010). In fact, mutations in either the gene encoding the telomerase
catalytic subunit (telomerase reverse transcriptase, TERT), or the telom-
erase RNA gene (TERC) are found in patients with dyskeratosis congenita
who have short telomeres and show accelerated aging and reduced
lifespan (Kirwan & Dokal, 2009). Consistently, late-generation (G3 and
beyond) TERT (Rudolph et al., 1999) or TERC-deficient mice (TERT/
and TERC/, respectively) are short living and show reduced fertility,
early alopecia, kyphosis, anemia, and lymphopenia (Wong et al., 2003).
Interestingly, TERC/ mice present altered mitochondrial functions,
including increased production of reactive oxygen species (ROS) from the
electron transfer chain (ETC) (Passos et al., 2010; Sahin et al., 2011).
Thereby, telomeres have been suggested to play a role in controlling
mitochondrial ROS accumulation and oxidative stress during aging (Sahin
& Depinho, 2010).
As telomere DNA is particularly sensitive to oxidative damage (Oikawa
& Kawanishi, 1999) and single-strand breaks or other stress-induced
lesions at telomeres are inefficiently repaired (Petersen et al., 1998),
oxidative stress is considered to accelerate telomere erosion (von
Zglinicki, 2002; Houben et al., 2008). Consistently, mice expressing a
variant of the mitochondrial uncoupling protein 2 that increases ROS
production by ETC, and therefore, oxidative stress shows short telomeres
(Salpea et al., 2010). Moreover, it has been shown that treating mouse
embryos with chemicals able to induce mitochondrial dysfunction and
ROS accumulation, led to telomere loss and chromosomal instability,
which was prevented by a concomitant treatment with N-acetylcysteine,
a compound that improves ROS scavenging (Liu et al., 2002). However,
other mutations in genes involved in ROS metabolism, such as SOD2
haploinsufficiency, do not cooperate with telomere dysfunction (Gua-
challa et al., 2009), and the treatment with N-acetylcysteine does not
rescue progeric phenotypes of late-generation TERT-deficient mice
(Sahin et al., 2011).
P66SHC protein is the largest isoform encoded by the ShcA locus,
typical of vertebrates, and it sustains intracellular levels of ROS (Giorgio
et al., 2005 Gertz & Steegborn, 2010) and regulates redox signaling
pathways (Frijhoff et al., 2014), mitochondrial apoptosis (Migliaccio
et al., 2006), and aging (Trinei et al., 2009). P66SHC null mice
(p66SHC/) develop normally and resulted to be protected from
aging-associated diseases, such as atherosclerosis (Martin-Padura et al.,
2008), diabetes compliances (Menini et al., 2007), onset (Tomilov et al.,
2011), cognitive decline (Berry et al., 2007), and neurodegeneration
(Savino et al., 2013). Moreover, p66SHC null cells were shown to be
resistant to apoptosis induced by a variety of different signals, including
hydrogen peroxide, UV, staurosporine, taxol, growth factor deprivation,
calcium ionophore, osmotic shock, and CD3–CD4 cross-linking (as
reviewed in Migliaccio et al., 2006). Similarly, different tissues of
p66SHC/ mice were found to be resistant to apoptosis induced by
paraquat (Migliaccio et al., 1999), hypercholesterolemia (Napoli et al.,
2003), hyperglycemia (Menini et al., 2007), immunotoxicity (Su et al.,
2012), and ischemia/reperfusion injury (Carpi et al., 2009). At mecha-
nistic level, substantial evidence indicates that p66SHC regulates redox
balance and mitochondrial apoptosis by suppressing ROS scavenging
and increasing ROS production from plasma membrane oxidases and
mitochondria where, in particular, p66SHC favors H2O2 production by
ETC (Gertz & Steegborn, 2010; Trinei et al., 2013). Accordingly,
p66SHC/ tissues showed a reduced level of oxidative damage to
nuclear and mitochondrial DNA (Trinei et al., 2002), lipids (Napoli et al.,
2003), carbohydrates (Menini et al., 2007), and proteins (Carpi et al.,
2009), which can be either unspecifically or specifically (e.g., redox-
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regulated phosphatases; Frijhoff et al., 2014) damaged by oxidative
stress.
To investigate the link between endogenously generated oxidative
stress, telomeres, and aging, we have investigated the effect of p66SHC
deletion on late-generation TERC-deficient mice, by generating and
studying double mutants TERC/ P66SHC/ mice.
Results
The deletion of p66SHC improves fertility of late-generation
TERC/ mice
At first, we backcrossed TERC+/ male with C57Bl6/J wild-type (WT)
female mice to generate TERC+/ mice in pure C57Bl/6 background
(100% C57BL/6 according to the Marker-Assisted Accelerated Back-
crossing, MAX-BAX, analysis). These mice were bred together to
generate TERC/ (p66SHC+/+) mice that were bred successfully, by
crossing mice of the same generation, up to the fifth generation (G5), as
already reported (Rudolph et al., 1999).
Then, we crossed C57Bl/6J TERC+/ female with pure C57Bl/6J
p66SHC/ male mice and selected TERC+/ p66SHC+/ double
heterozygous mice among the resulting litters. These mice were then
crossed together and litters genotyped for TERC and p66SHC mutations
(Fig. 1A). The resulting TERC/ p66SHC+/ mice were selected as the
first generation (G1) of TERC null mice and were bred together to
segregate into three genotypes: p66SHC/, p66SHC+/, and p66SHC+/
+ (Table 1). In this way, we obtained G2 TERC/ p66SHC+/+ and G2
TERC/ p66SHC/ mice that were propagated as distinct colonies by
breeding mice from the same generations (Fig. 1B). As observed for the
other colonies of TERC/ mice, at G5 TERC/ p66SHC+/+ crosses were
not fertile, as well as the crosses of males (or females) G5 TERC/
p66SHC+/+ with WT female (or male) mice. On the opposite, half of the
crosses of G5 and also approximately a third of the G6 TERC/
p66SHC/ mice were fertile, and thus, it was possible to generate G7
TERC/ p66SHC/ mice (Fig. 2A).
The average number of pups per dam was comparable between G2
TERC/ p66SHC+/+ and G2 TERC/ p66SHC/ mice, as well as
between WT and p66SHC/ animals (Giorgio et al., 2012). At G3,
TERC/ p66SHC+/+, but not TERC/ p66SHC/, mice showed a
significant fertility reduction. Only, at G5, we observed a decrease in
litter size of TERC/ p66SHC/ mice (Fig. 2B).
Furthermore, we crossed G3 TERC/ p66SHC+/+ females with
TERC/ p66SHC/ male mice to produce G4 TERC/ p66SHC+/
mice. By crossing these mice, we could segregate other G5 TERC/
p66SHC+/+ animals. Interestingly, one of four crosses of these G5 TERC/
 p66SHC+/+ was fertile and two males of four of the resulting G6
TERC/ p66SHC+/+ litter were able to generate offspring when crossed
with WT females.
These data clearly suggest that p66SHC deletion improves fertility of
late-generation TERC/ mice.
The deletion of p66SHC prevents DNA oxidative damage but
not telomere shortening in TERC/ mice
Eight-hydroxy-2-deoxy guanosine (8-OH-dG) and isoprostanes are
recurrent oxidized DNA base and fatty acids products, respectively, that
marks oxidative stress to DNA and lipids and were found reduced in
p66SHC/ mice (Trinei et al., 2002; Napoli et al., 2003; Lunghi et al.,
2015). We have measured the content of 8-OH-dG in the genomic DNA
extracted from liver, spleen, lung, and testis of G0 and G3; and liver and
spleen of G5 TERC/ p66SHC+/+ or TERC/ p66SHC/ 6-month-old
mice using a competitive ELISA assay with specific anti-8-OH-dG
antibody and of 8-iso-PGF2a (8-isoprostane) by immunohistochemistry
analysis of tissue sections from testis, lung, and liver of G0 and G3,
TERC/ p66SHC+/+, and TERC/ p66SHC/mice. Results showed that
the deletion of p66SHC reduced the amount of 8-OH-dG (Fig. 3A) and
of 8-isoprostane (Fig. 3B) in TERC/ genetic background as well.
To determine telomere length, we performed qPCR analysis of
telomeric sequences in genomic DNA extracted from skin, spleen, and
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Fig. 1 Genealogy of TERC/ p66SHC+/+ and TERC/ p66SHC/ mice. (A) PCR
genotype analysis for TERC (left panel) and p66SHC mutation (right panel). (B)
Scheme of the crosses performed to generate the different generations of TERC/
p66SHC+/+ and TERC/ p66SHC/ mice.
Table 1 Frequency of p66SHC+/+, p66SHC+/, and p66SHC/ genotypes in the
progeny obtained crossing G1 TERC/ p66SHC+/ mice
GENOTYPE Number Males Females
Expected
(%)
Observed
(%)
TERC/P66SHC+/ 35 18 17 50 57.4
TERC/P66SHC+/+ 10 6 4 25 16.4
TERC/P66SHC/ 16 8 8 25 26.2
Total 61 32 29 100 100
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liver of 6-month-old G3–G5 TERC/ p66SHC+/+, G3-G7 TERC/
p66SHC/, and WT mice (Fig. 3C), and quantitative fluorescent
in situ hybridization (Q-FISH) analysis on tissue sections from liver, lung,
heart, and testis of 6-month-old G0, G3, and G5 TERC/ p66SHC+/+ or
TERC/ p66SHC/ mice (Figs 3 D and E and S1 in Supporting
information). As expected, we observed a progressive telomere short-
ening in successive generations of TERC/ mice, particularly in the skin
by the qPCR analysis and more evident in all the tissues by Q-FISH.
However, the TERC/ p66SHC+/+ and TERC/p66SHC/ showed a
similar telomere decline, suggesting that p66SHC does not contribute to
telomere erosion.
The deletion of p66SHC prevents weight loss and organ
shrinkage in late-generation TERC/ mice
Along with reduced fertility, starting from G3, C57Bl6/J TERC/ mice
showed signs of premature aging as already reported (Wong et al.,
2003; Siegl-Cachedenier et al., 2007). At first sight, young adult (2–
3 months old) TERC/ p66SHC+/+ mice exhibited alopecia on the back
and kyphosis and were of smaller size compared to G3 TERC/
p66SHC/ mice that appeared bigger and healthier (Fig. 4A). At G5,
TERC/ p66SHC+/+ mice were significantly smaller compared to age-
matched TERC/ p66SHC/mice (Fig. 4B). We observed a reduction in
the size and weight (Fig. 4C) of a number of organs including liver,
spleen, kidneys, and testis, in late-generation TERC/ p66SHC+/+ mice;
in particular, starting from G3 these mice presented testis atrophy that,
however, was not observed in TERC/ p66SHC/ mice (Fig. 5A).
Notably, the frequency of apoptotic cells as evaluated by IHC analysis
with anti-activated caspase-3 antibody appeared significantly reduced in
the testis from p66SHC/ background (Fig. S2). Aplastic anemia has
been also associated to telomere shortening in both humans and mouse
models (Siegl-Cachedenier et al., 2007); however, blot tests and bone
marrow examination did not evidence severe aplastic anemia either in
TERC/ p66SHC+/+ or TERC/ p66SHC/ mice (Fig. 5B). No clear
signs of muscle degeneration but rare loss of the striations, vacuoliza-
tion, and infiltrations in the G3 TERC/ p66SHC+/+, as shown in the
Fig. S3, were observed. Abnormal glycaemia was not revealed in all
generations as well. Lung emphysema was observed in late-generation
TERC/ regardless the p66SHC genotype, whereas lung fibrosis was
markedly evident in p66SHC/ mice (Fig. 5C).
P66SHC does not affect the lifespan of late-generation TERC/
 mice
G3 C57Bl/6 TERC/ mice were shown to be short living (Rudolph et al.,
1999). The comparisonof survival curves ofWTandG3 TERC/ p66SHC+/
+ mice confirmed this observation (Fig. 6A). In particular, mortality risk
(Fig. 6A, right upper panel) was comparable for the first 2 years, whereas
starting from the third year it increases muchmore for TERC/mice than
for WT; G3 TERC/ p66SHC+/+ males showed the shortest survival.
The survival rate of G3 TERC/ p66SHC/ was identical to that of
G3 TERC/p66SHC+/+ mice (Fig. 6B). They showed the same reduction
in survival compared to the WT and p66SHC/ (TERC+/+) mice. We
could also determine the lifespan of G6 TERC/ p66SHC/ mice,
revealing a further shortening of lifespan with respect to the G3
(Fig. 6C). Necroscopic examination of spontaneously dead G3 and G6
mice revealed the presence of visible tumor masses only in few cases (12
of 100 mice), equally distributed with respect to p66SHC mutation, rare
enlargement of bladder and fecal prolapse, no splenomegaly or enlarged
lymph nodes, and no hemorrhagic tissues or ascites.
In particular, the average body weight of G6 TERC/ p66SHC/
mice was 18.5  0.4 g at 3 months of age and 23.1  1.8 g at 1 year
of age. They showed tremor and lethargy because 6–8 months of age
and frequently hair loss around the nose and the limb, no abnormalities
in the blood formula but a mild anemia, normal glycaemia and lipidic
profile, and small lungs and thymus at death.
Discussion
Consecutive crosses of TERC/ mice originate individuals with insuffi-
cient telomere length, organ dysfunctions, low fertility, and short
lifespan (Wong et al., 2003 and Fig. 6A).
Oxidative stress shortens telomeres (von Zglinicki, 2002), and the
deletion of p66SHC reduces oxidative stress (Trinei et al., 2002 and
Fig. 3A and B). However, in the double mutants (TERC/ p66SHC/)
mice, we do not observe differences of telomere length with respect to
the TERC/ p66SHC+/+ (Fig. 3 C and D). This result indicates that the
effect of reducing oxidative damage, by deleting p66SHC, on telomere
shortening is less important with respect to other reasons of telomere
erosion such as the incomplete replication of chromosomal ends.
The function of p66SHC appears instead relevant for the downstream
consequences of dysfunctional chromosome ends, as p66SHC deletion
improved fertility and reduce weight and shrinkage of different organs
including testis of late-generation TERC/ mice (Fig. 4). Short telomeres
of late-generation TERC/ mice induce senescence and apoptosis
(Wong et al., 2003) that determine the detrimental effects of telomere
erosion ultimately. P66SHC triggers mitochondrial apoptosis upon a
variety of stresses (Migliaccio et al., 2006). At mechanistic level, p66SHC
is plausible to mediate cell loss following telomere erosion rather than
having a role in telomere shortening.
Regardless of the recovered fertility, weight, and healthier appearance,
the p66SHC deletion does not improve longevity of G3 TERC/ mice
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(Fig. 6B). Indeed, lung emphysema and fibrosis are frequent in both G3
and later generations of TERC/ independently by the p66SHC deletion,
althoughwe could not establish that lungdysfunction is the cause of death
of these mice. Histiocytic sarcoma was reported to be the most frequent
tumor lesion in C57Bl/6 mice, including p66SHC/ (Ramsey et al., 2014)
and TERC/ (Khoo et al., 2007)models. In any case, the early mortality of
TERC/ mice is not determined by p66SHC suggesting that oxidative
stress and telomere attrition donot cooperate to determine lifespan. In this
view, theunificationofmitochondrial (free radicals) andnuclear (telomere)
theories of aging (Sahin & DePinho, 2012) appears uncertain since the
peculiar reasons of death of laboratory C57BL/6 mice.
From an evolutionary point of view, short telomeres and repressed
telomerase (as in human somatic tissues) have been suggested to co-
evolve with homeothermy and replicative aging in mammals (Gomes
et al., 2011), while p66SHC with the metabolic adaptation to harsh
energetic environments (i.e., food deprivation and cold temperature)
(Giorgio et al., 2012). In this view, the relative healthier aging of TERC/
 p66SHC/ compared to TERC/ p66SHC+/+ mice suggests that the
cost to pay for having a plastic metabolism (as ensured by p66SHC) is to
amplify the negative effect of telomere erosion on body size and fertility.
Finally, results from the study of p66SHC/TERC support the notion that
genetic factors control the response to telomere erosion of specific organs.
Thus, the predictive value of telomere length on organ aging depends on
genetic background. Then, p66SHC expression and activity is induced in
several tissues by obesogenic diets (Giorgio et al., 2012) or hyperglycemia
(Albiero et al., 2014) that are known to affect telomere length as well
(Laimer et al., 2015). The interaction of aging and metabolic pathways,
including p66SHC, SIRT1, or AMPK/mTOR/S6K (Fadini et al., 2011), with
telomere erosion in the presence of diabetes or obesity is a promising field
to reveal how metabolic disorders impact on aging.
Experimental procedures
Mice
P66SHC mice were generated in our laboratory, at the European
Institute of Oncology (Milan, Italy); TERC+/ mice (Lee et al., 2001)
originated from the laboratory of Ronald DePinho (Dana-Farber Cancer
Institute, 450 Brookline Ave. Boston, MA, USA), and WT C57Bl6/j mice
were purchased from Charles River Laboratories, Italy. All mice were
housed at the specific-pathogen-free FELASA-certified mouse facility in a
temperature-controlled room (temperature 21  1 °C, relative humidity
60  10%) under a 12-h light/12-h dark cycle (lights on from 7:00 a.m.
to 7:00 p.m.) and with ad libitum food availability (2018S Teklad Global
18% Protein Rodent Diet; Harlan Laboratories Lesmo, Italy) and drinking
water (autoclaved tap water). Proper group housing (four animals per
cage) was chosen to improve animal welfare. Home cages were Plexiglas
boxes (42 9 27 9 14 cm) with sawdust as bedding.
25
30
35
40
10
20
15B
O
D
Y
 W
E
IG
H
T 
(g
)
G3 1 year
p66SHC+/+
p66SHC–/–
MF
G3 2 years
MF
G4 1 year
MF
G4 2 years
MF
G5 1 year
MF
G5 2 years
MF
** ** **
**
** **
G5 TERC–/– P66SHC+/+
G5 TERC–/– P66SHC–/–
A
B
C
0
O
R
G
A
N
 W
E
IG
H
T 
(g
) 
p66SHC+/+
p66SHC–/–
G3 G5G0
0.5
1.0
1.5
2.0
0
G3 G5G0
0.05
0.1
0.15
0.2
0.25
0
SPLEEN 
0.3
G3G0
*
**
G5 TERC–/– P66SHC–/–
G5 TERC–/– P66SHC+/+
0.02
0.04
0.06
0.08
0.1
0
0.12
G3G0
*
KIDNEY LIVER
**
TESTIS 
0.05
0.1
0.15
0.2
0.25
G5
Fig. 4 Appearance and weight of TERC/ p66SHC+/+ and TERC/ p66SHC/ mice. (A) Representative images of 3 months old G5 TERC/ p66SHC+/+ and TERC/
p66SHC/ mice. (B) Mean body weight of TERC/ p66SHC+/+ and TERC/ p66SHC/ mice at 1 and 2 years of age (F, female; M, male), *for p < 0.05 ** for P < 0.01.
(C) Kidney, testis, spleen, and liver weight of G0–G5 TERC/ p66SHC+/+ and TERC/ p66SHC/ mice.
P66SHC mediates telomere loss-made sterility, M. Giorgio et al.450
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Experiments have been carried out in accordance with institutional
guidelines and the Italian law, which enforces EU directives regarding the
protection of animals used for experimental and other scientific purpose.
TERC and p66SHC genotyping
The primers and reaction conditions used for PCR genotyping were as
follows: for TERC mouse mutants, 50 GGG GCT GCT AAA GCG CAT 30;
50 TTC TGA CCA CCA CCA ACT TCA AT 30; 50 CTA AGC CGG CAC TCC
TTA CAA G 30; and reactions: 95 °C 15 min, 94 °C 1 min, 55 °C
1 min, 72 °C 1 min (35 cycles), 72 °C 7 min. For p66SHC mouse
mutants: 50 CTC GTG TGG GCT TAT TGA CAA AG 30; 50 CCT CCC CAG
GTC ATC TGT TAT CC 30; 50 GGG TGG AGA GGC TTT TTG CTT C 30; and
reactions: 95 °C 15 min, 94 °C 1 min, 64 °C 1 min, 72 °C 1 min
(35 cycles), 72 °C 7 min.
Telomere length qPCR and Q-FISH assays
All buffers were purged with nitrogen and supplemented with 50 lM
phenyl-tert-butyl nitrone (Sigma-Aldrich Milan, Italy Srl) to prevent
oxidation and minimize oxidative damage to DNA, which may alter the
efficiency of the PCR if abasic sites are generated. Genomic DNA was
isolated from mouse tissues using the silica-gel-membrane-based
DNeasy Tissue Kit (QIAGEN, Italy Srl Milan, Italy), according to the
manufacturer’s protocol with minor modifications. To minimize abasic
site generation, the initial high temperature lysis with proteinase K was
replaced by 6 hours incubation at 37 °C. Following the elution of
purified DNA, 1 mM DTT (dithiothreitol) was added to the DNA samples,
which were stored at 80 °C until use. DNA was quantified in triplicate
using a NanoDrop spectrophotometer (Thermo Fisher Scientific Inc.
Waltham, MA USA). Each PCR (20 lL) was performed as follows: 20 ng
DNA, 1 9 SYBR Green master mix (Life Technologies-Applied Biosys-
tems Italia Monza, Italy), 100 nM telomere forward primer (CGG TTT GTT
TGG GTT TGG GTT TGG GTT TGG GTT TGG GTT), and 100 nM telomere
reverse primer (GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC CCT
TAC CCT) (O’Callaghan et al., 2008). Results are from the measure of
three individuals per group performed in quadruplicates.
Q-FISH was performed on 5 lm deparaffinized sections treated with
0.1 mg mL1 RNA A solution and then with 0.5 mg mL1 proteinase K
solution for20 min each timeat 37 oC. Sliceswere thenprewarmedat 85 oC
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B
Fig. 5 Phenotypic characterization of TERC/ p66SHC+/+ and TERC/ p66SHC/ mice. (A) Representative images of morphology (left) and histology (right) of testes
from TERC/ p66SHC+/+ and TERC/ p66SHC/mice. (B) Blood counts (upper table: WBC 103/lL, RBC 106/lL, PLT 103/lL, HGB mg dL1; n = 6 mice per group) and bone
marrowhistology of TERC/p66SHC+/+ and TERC/p66SHC/mice. (C) Histological examination of lung tissues fromG5TERC/p66SHC+/+ and TERC/p66SHC/mice.
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for 5 min and incubated with 200 nM solution of Cy3 conjugated PNA TelC
probe (PNA Bio) in 60% formamide, 10 mM Tris–HCl pH 7.5, and
0.2 lg mL1 salmon sperm first for 10 min at 85 oC and then for 2 h at
RT. Then, the probewaswashes twicewith 2XSSC, 0.1%Tween-20 solution
for 10 min at 58 oC. DAPI staining was used for the staining of the nucleus.
Images were collected through an Olympus BX51 upright fluorescent
microscope equipped with a cool snap EZ CCD camera (Photometrics
Tucson, AZ, USA) and processed by Metamorph (Molecular Device
Sunnyvale, CA, USA) and ImageJ software. The Cy3 fluorescence
intensity of at least 40 nuclei observed in at least two different slices per
experimental group was compared (Meeker et al., 2002).
8-OH-dG and 8-isoprostane analysis
8-OH-dG was measured using the commercially available immunoassay
kit (Abcam Cambridge, UK) on genomic DNA. One microgram of total
genomic DNA was denatured 5 min at 95 °C and digested with nuclease
P1 (Sigma-Aldrich Srl), then dephosphorylated by incubation with
Antarctic phosphatase (New England Biolabs; EuroClone S.P.A. Pero,
Italy) and loaded in duplicate on the anti-8-OH-dG antibody-coated
plate. The amount of 8-OH-dG in the samples was quantified by
measuring competition with labeled 8-OH-dG for antibody binding.
8-isoprostane was detected by immunohistochemistry on deparaf-
finized 10 lm sections upon unmasking treatment for 45 min at 90 oC
with sodium citrate, 10 min of peroxide blocking at RT and decoration
with anti-8-epi-PGF2a (Oxford Biomedical Research Rochester Hills, MI,
USA) diluted 1:500 as primary antibody, and then with biotinylated anti-
goat and VECTASTAIN ABC Kit (Vector laboratories Burlingame, CA, USA)
followed by minimal counterstaining with hematoxylin.
Tissue analysis
Blood formula was obtained using the Haematological Analyzer Act 5
Diff (Beckman Dickinson Franklin Lakes, NJ, USA). Histological analysis
400 500 600 700 800 900 1000 1100
0
25
50
75
100
A
B C
Av. LS 800** LD50 820**
Av. LS 722** LD50 720**
Days
S
ur
vi
va
l (
%
)
WT
G3 TERC–/– P66SHC+/+
WT
G3 TERC–/– P66SHC+/+
400 500 600 700 800 900 1000 1100
0
1
2
3
4
Days
H
az
ar
d
5
400 500 600 700 800 900
0
25
50
75
100
Av. LS 693**  LD50 718**
Av. LS 522**  LD50 504**
G6 TERC–/– P66SHC–/–
400 500 600 700 800 900 1000 1100
0
25
50
75
100
Days
S
ur
vi
va
l (
%
)
WT Females  
G3 Females
TERC–/– P66SHC+/+
400 500 600 700 800 900 1000 1100
0
25
50
75
100
Days
S
ur
vi
va
l (
%
)
WT Males
G3 Males
TERC–/– P66SHC+/+
S
ur
vi
va
l (
%
)
G3 TERC–/– P66SHC–/–
400 500 600 700 800 900
0
25
50
75
100
Av. LS 722  LD50 720
Av. LS 693  LD50 718
G3 TERC–/– P66SHC–/–
S
ur
vi
va
l (
%
)
G3 TERC–/– P66SHC+/+
Days Days
Fig. 6 Survival curves of WT, TERC/ p66SHC+/+, and TERC/ p66SHC/ mice. (A) Left upper graph, WT (n = 40) and G3 TERC/ p66SHC+/+ (n = 18) male and
female mice (Av. LS, average lifespan; LD50, median life time; **P < 0.01 for the effect of TERC genotype); right upper graph, cumulative hazard function for WT and G3
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was performed on fresh tissues that were rapidly washed in PBS and
incubated in 4% formaldehyde-buffered solution for 16 h at room
temperature. Fixed samples were then dehydrated by increasing
concentrations of ethanol and included in paraffin using the Leica
ASP300 tissue processor (Leica Biosystems – Leica Microsystems Srl
Milan, Italy). Then, 4 lm sections were cut from paraffin blocks and
stained with hematoxylin–eosin. Anti-active caspase 3 antibody (Abcam)
was used to reveal apoptotic cells by IHC.
Statistical analysis
Data were analyzed using Student’s t-test and Fisher’s exact test. Survival
was estimated with Kaplan–Meier estimators and differences tested with
the log rank test.
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Fig. S1 Representative FISH images of sections of different organs from G0,
G3 and G5 TERC/P66SHC+/+ and TERC/p66SHC/ mice, stained with
the Cy3 conjugated TelC PNA probe (grayscale panels), the colored panels
show Cy3 and DAPI fluorescence pattern in a stained section of WT liver as
control.
Fig. S2 IHC analysis of testis slices from G3 and G5 TERC/ p66SHC+/+ and
TERC/ p66SHC/ mice with anti-activated caspase 3 antibody.
Fig. S3 HE stained sections of quadriceps fromG0 and G3 TERC/p66SHC+/+
or p66SHC/ mice.
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